229 related articles for article (PubMed ID: 34354161)
1. Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease.
Donate-Correa J; Ferri CM; Martín-Núñez E; Pérez-Delgado N; González-Luis A; Mora-Fernández C; Navarro-González JF
Sci Rep; 2021 Aug; 11(1):15877. PubMed ID: 34354161
[TBL] [Abstract][Full Text] [Related]
2. A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.
Kitagawa M; Sugiyama H; Morinaga H; Inoue T; Takiue K; Ogawa A; Yamanari T; Kikumoto Y; Uchida HA; Kitamura S; Maeshima Y; Nakamura K; Ito H; Makino H
PLoS One; 2013; 8(2):e56695. PubMed ID: 23431388
[TBL] [Abstract][Full Text] [Related]
3. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m
Donate-Correa J; Martín-Núñez E; Martin-Olivera A; Mora-Fernández C; Tagua VG; Ferri CM; López-Castillo Á; Delgado-Molinos A; López-Tarruella VC; Arévalo-Gómez MA; Pérez-Delgado N; González-Luis A; Navarro-González JF
Front Endocrinol (Lausanne); 2023; 14():1146012. PubMed ID: 37274332
[TBL] [Abstract][Full Text] [Related]
4. Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?
Căpuşă C; Ştefan G; Stancu S; Lipan M; Tsur LD; Mircescu G
Medicine (Baltimore); 2017 Nov; 96(47):e8802. PubMed ID: 29381982
[TBL] [Abstract][Full Text] [Related]
5. The relationship between asymptomatic atherosclerosis and hepcidin-25 in chronic kidney disease patients.
Mohamed ON; Mady AM; Sedik MM; Issa AS; Mohamed OM; Abdelhameed NI
Ann Saudi Med; 2023; 43(5):298-308. PubMed ID: 37805814
[TBL] [Abstract][Full Text] [Related]
6. Association of Mild-to-Moderate Reduction in Glomerular Filtration Rate with Subclinical Atherosclerosis in Postmenopausal Women.
Parv F; Beceanu A; Avram R; Timar RZ; Timar B; Gadalean F
J Womens Health (Larchmt); 2017 Nov; 26(11):1201-1213. PubMed ID: 28537783
[TBL] [Abstract][Full Text] [Related]
7. Subclinical cardiovascular disease assessment and its relationship with cardiovascular risk SCORE in a healthy adult population: A cross-sectional community-based study.
Mitu O; Roca M; Floria M; Petris AO; Graur M; Mitu F
Clin Investig Arterioscler; 2017; 29(3):111-119. PubMed ID: 28377040
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.
Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E;
Nephrol Dial Transplant; 2017 Mar; 32(3):513-520. PubMed ID: 27190385
[TBL] [Abstract][Full Text] [Related]
9. Cardio-ankle vascular index is linked to deranged metabolic status, especially high HbA1c and monocyte-chemoattractant-1 protein, in predialysis chronic kidney disease.
Mert M; Dursun B; Yağcı AB; Çetin Kardeşler A; Şenol H; Demir S
Int Urol Nephrol; 2020 Jan; 52(1):137-145. PubMed ID: 31773386
[TBL] [Abstract][Full Text] [Related]
10. Subclinical atherosclerosis measures for cardiovascular prediction in CKD.
Matsushita K; Sang Y; Ballew SH; Shlipak M; Katz R; Rosas SE; Peralta CA; Woodward M; Kramer HJ; Jacobs DR; Sarnak MJ; Coresh J
J Am Soc Nephrol; 2015 Feb; 26(2):439-47. PubMed ID: 25145930
[TBL] [Abstract][Full Text] [Related]
11. Value of the arterial stiffness index and ankle brachial index in subclinical atherosclerosis screening in healthy community-dwelling individuals.
Alizargar J; Bai CH
BMC Public Health; 2019 Jan; 19(1):65. PubMed ID: 30646893
[TBL] [Abstract][Full Text] [Related]
12. Plasma MicroRNA-29c Levels Are Associated with Carotid Intima-Media Thickness and is a Potential Biomarker for the Early Detection of Atherosclerosis.
Huang YQ; Li J; Huang C; Feng YQ
Cell Physiol Biochem; 2018; 50(2):452-459. PubMed ID: 30308507
[TBL] [Abstract][Full Text] [Related]
13. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
Silva AP; Mendes F; Carias E; Gonçalves RB; Fragoso A; Dias C; Tavares N; Café HM; Santos N; Rato F; Leão Neves P; Almeida E
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934737
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.
Yilmaz G; Ustundag S; Temizoz O; Sut N; Demir M; Ermis V; Sevinc C; Ustundag A
Clin Lab; 2015; 61(8):1061-70. PubMed ID: 26427152
[TBL] [Abstract][Full Text] [Related]
15. Associations of work hours with carotid intima-media thickness and ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA).
Charles LE; Fekedulegn D; Burchfiel CM; Fujishiro K; Landsbergis P; Diez Roux AV; Macdonald L; Foy CG; Andrew ME; Stukovsky KH; Baron S
Occup Environ Med; 2012 Oct; 69(10):713-20. PubMed ID: 22767870
[TBL] [Abstract][Full Text] [Related]
16. Plasma klotho levels were inversely associated with subclinical carotid atherosclerosis in HIV-infected patients receiving combined antiretroviral therapy.
Jeong SJ; Song JE; Kim SB; Kim HW; Ku NS; Han SH; Choi JY; Song YG; Cha BS; Kim JM
AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1575-81. PubMed ID: 23941507
[TBL] [Abstract][Full Text] [Related]
17. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
[TBL] [Abstract][Full Text] [Related]
18. Serum fibroblast growth factor 23 levels do not correlate with carotid intima-media thickness in patients with chronic kidney disease.
Kaya B; Seyrek N; Paydas S; Karayaylali İ; Balal M; Aikimbaev K
Saudi J Kidney Dis Transpl; 2019; 30(5):1010-1021. PubMed ID: 31696838
[TBL] [Abstract][Full Text] [Related]
19. [New markers of cardio-renal links in chronic kidney disease].
Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594
[TBL] [Abstract][Full Text] [Related]
20. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study.
Arroyo D; Betriu A; Martinez-Alonso M; Vidal T; Valdivielso JM; Fernández E;
BMC Nephrol; 2014 Oct; 15():168. PubMed ID: 25326683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
